Advances in Precision Therapeutics and Gene Therapy Applications for Retinal Diseases: Impact and Future Directions.

Genes (Basel) · 2025 · PMC12294471 · PMID 40725503

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Nevertheless, measured using Humphrey visual field testing, the improvements in best-corrected visual acuity (BCVA) and macular sensitivity did not reach statistical significance [ 3 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.